MoonLake Immunotherapeutics (NAS:MLTX)
$ 40.92 -1.05 (-2.5%) Market Cap: 2.57 Bil Enterprise Value: 2.03 Bil PE Ratio: 0 PB Ratio: 4.74 GF Score: 24/100